About GeNouRoB
GeNouRoB is a company based in Laval (France) founded in 2007. GeNouRoB has raised $417.81 thousand across 4 funding rounds from investors including Siparex, GO CAPITAL and European Union. GeNouRoB offers products and services including GNRB, DYNEELAX, and SPINEO. GeNouRoB operates in a competitive market with competitors including Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.
- Headquarter Laval, France
- SectorsHealthcare
- Email••••••••
- Website genourob.com
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$417.81K (USD)
in 4 rounds
- Latest Funding Round$55.05K (USD), Grant
Nov 2019
- InvestorsSiparex
& 3 more
Products & Services of GeNouRoB
GeNouRoB offers a comprehensive portfolio of products and services, including GNRB, DYNEELAX, and SPINEO.
Device for automated knee laxity and ACL injury assessment.
Motorized tool for precise ligament analysis and diagnostics.
Patented device for spine therapy and back pain management.
Apps and channels of GeNouRoB
its YouTube channel Genourob Official has 109 subscribers and 30 videos.
Videos from GeNouRoB
The most watched videos on GeNouRoB's YouTube channel, Genourob Official (109 subscribers). Click a video to play it here.
More on Genourob Official.
Funding Insights of GeNouRoB
GeNouRoB has successfully raised a total of $417.81K across 4 strategic funding rounds. The most recent funding activity was a Grant round of $55.05 thousand completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $417,812
- Total Rounds 4
- Last Round Grant — $55,048
- First Round $417,812
(Jun 2011)
- Investors Count 4
All 4 funding rounds of GeNouRoB with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2019 | $55,048 | Grant | – | – | |
| Jul 2019 | $56,436 | Grant | – | – | |
| May 2015 | – | Seed | – | – | |
| Jun 2011 | $417,812 | Seed | – | – |
4 investors in total: 4 institutional.
Investors in GeNouRoB
GeNouRoB has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Siparex, GO CAPITAL and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Private equity investments are focused on growth stage companies. | 1977 | siparex.com | Paris, France | |
Private equity investments are directed toward multiple sectors. | 2003 | gocapital.fr | Rennes, France | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for GeNouRoB
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of GeNouRoB
3 dated milestones of GeNouRoB across 12 years, from founding to its latest funding, stage changes and deals.
- Founded GeNouRoB is founded.
- Funding First funding round of $418K.
- Funding Latest funding round, Grant, of $55K.
Competitors of GeNouRoB
GeNouRoB operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tricemedical.com | 2012 | King Of Prussia, United States | $85.47M | 67 | Needle-based visualization devices for orthopedic diagnostics are developed. | |
| edgesurgical.com | 2015 | Chicago, United States | $16.99M | – | Digital depth gauges for orthopedic bone measurements are supplied. | |
| orthoscan.com | 2002 | Scottsdale, United States | $8.33M | 148 | Mini C-arms for orthopedic imaging are developed by OrthoScan. | |
| onicorp.com | 1997 | Boston, United States | $28M | – | MRI systems for extremity imaging are developed and marketed. | |
| bindex.fi | 2011 | Kuopio, Finland | – | – | Ultrasound-based POC device for osteoporosis screening is developed. | |
| rossumrobot.cn | 2017 | Haidian, China | $14.33M | – | Robotic surgical systems for orthopedic treatments are provided. | |
| echolightmedical.com | 2010 | Lecce, Italy | $4.4M | – | Radiation-free bone densitometers for osteoporosis assessment are developed. | |
| activelifescientific.com | 2007 | Santa Barbara, United States | $3.26M | 6 | Bone and tissue quality measurement devices are developed. | |
| hemics.com | 2011 | Eindhoven, Netherlands | – | – | Imaging devices for rheumatoid arthritis detection are developed by Hemics. |
Detailed competitors of GeNouRoB
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GeNouRoB
The website of GeNouRoB (genourob.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 61.2% vs previous month
Websites whose visitors overlap most with GeNouRoB. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
google.fr | google.fr | 100% | – | #273 | – |
Similar companies to GeNouRoB
10 companies that operate in the same segment as GeNouRoB (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | – | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GeNouRoB
GeNouRoB was founded in 2007 and raised its 1st funding round 4 years after it was founded.
GeNouRoB is headquartered in Laval, France.
GeNouRoB is a funded company, having raised a total of $417.81K across 4 funding rounds to date. The company's 1st funding round was a Seed of $417.81K, raised on Jun 2011.
Founded in 2007 in Laval, France, the company focuses on the medical devices sector. Devices and associated software are designed, produced, and marketed for assessing knee ligament structures and performance. Automated dynamic laximetry tools are utilized to measure laxity through standardized tests. Products are distributed in over 18 countries, supporting clinical evaluations and rehabilitation processes.
GeNouRoB's top competitors include Edge Surgical, Trice Medical and Echolight Medical.
GeNouRoB offers GNRB, DYNEELAX, and SPINEO.
GeNouRoB has 4 investors. Key investors include Siparex, GO CAPITAL, European Union, and EIC Fund.